what does nectar lifesciences do

Nectar Lifesciences Limited is a pharmaceutical company that specializes in manufacturing Active Pharmaceutical Ingredients (APIs) and Formulations, particularly focusing on Cephalosporin antibiotics, with a significant presence in India and international markets.

what products does nectar lifesciences make

Nectar Lifesciences Ltd. manufactures and sells pharmaceutical products including Cephalosporin APIs such as cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, and cefotaxime sodium, along with intermediates, primarily for both domestic and global markets.

what sector is nectar lifesciences in

Nectar Lifesciences Limited operates in the pharmaceutical sector, specifically within the sub-sector of Active Pharmaceutical Ingredients (APIs) and Formulations, contributing to the healthcare industry.

when was nectar lifesciences founded

Nectar Lifesciences Limited was incorporated in 1995, marking over two decades of operation in the pharmaceutical manufacturing field.

who owns nectar lifesciences

Nectar Lifesciences Limited is a publicly listed company on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), owned by its shareholders who are part of the Indian capital market system.

Nectar Lifesciences Limited (NECLIFE) Share Price Today — ₹13.82

Nectar Lifesciences Limited (NECLIFE) live stock price is ₹13.82 with a change of +1.92% today. Listed on NSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Nectar Lifesciences Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Nectar Lifesciences Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

NECLIFE

NSEBSE

Nectar Lifesciences Limited

Healthcare· Pharmaceuticals & Biotechnology· INE023H01027· Scrip: 532649

EN हिन्दी ગુજરાતી मराठी

₹13.82

▲ 0.26 (+1.92%)

8/5/2026, 9:46:35 am

NSE

₹13.82

▲ 0.26

+1.92%

BSE

₹12.51

▲ 0.72

+0.00%

244 trading days · 1Y period

TODAY 

Open13.77

High14.10

Low13.77

Prev Close13.56

Volume19.43Cr

Value₹0.0Cr

L: 13.77H: 14.10

52 WEEK

Low₹9.30

High₹28.25

24% of 52W range

Info

Face Value₹1

Listed2005-07-18

ISININE023H01027

SeriesB

BSE Scrip532649

Key Metrics

1D

+1.87%

1W

-2.28%

1M

+7.14%

3M

-22.91%

6M

-11.56%

Valuation

P/E (TTM)15.80

P/E (Qtr Ann.)8.58

P/Sales0.12

Mkt Cap₹194 Cr

Growth (QoQ)

Revenue+6.28%

PAT+40.03%

EPS+40.00%

Profitability

EBITDA Margin6.2%

Net Margin1.7%

TTM EBITDA M.5.8%

TTM Net M.1.0%

Dividend

Yield0.42%

Latest DPS₹0.05

Payout Ratio14.3%

Growth+0.00%

TTM Revenue

₹1684 Cr

TTM EBITDA

₹99 Cr

TTM PAT

₹17 Cr

TTM EPS

₹0.76

Rev/Share

₹86.7

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	455 Cr	443 Cr	28 Cr	13 Cr	8 Cr	₹0.35
2024-09-30	428 Cr	420 Cr	24 Cr	9 Cr	6 Cr	₹0.25
2024-06-30	359 Cr	355 Cr	20 Cr	5 Cr	3 Cr	₹0.13
2024-03-31	441 Cr	432 Cr	26 Cr	11 Cr	1 Cr	₹0.03
2023-12-31	452 Cr	450 Cr	18 Cr	2 Cr	2 Cr	₹0.07
2023-09-30	398 Cr	407 Cr	17 Cr	2 Cr	1 Cr	₹0.05
2023-03-31	389 Cr	405 Cr	16 Cr	2 Cr	4 Cr	₹0.16
2022-12-31	344 Cr	375 Cr	-3 Cr	-18 Cr	-9 Cr	₹-0.41

Shareholding Pattern

CURRENT — 2026-03-31

Promoter51.8%

FII0.6%

DII4.0%

Public48.2%

Govt0.0%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-12-24	Other	Buy Back
2024-09-13	Other	Annual General Meeting
2023-09-14	Other	Annual General Meeting
2022-09-13	Other	Annual General Meeting
2021-09-13	Other	Annual General Meeting
2020-09-11	Dividend	Annual General Meeting/Dividend - Rs 0.05 Per Share
2019-09-19	Dividend	Annual General Meeting/Dividend - Rs 0.05 Per Share
2018-09-19	Dividend	Annual General Meeting/Dividend- Re 0.05 Per Share
2017-09-20	Dividend	Annual General Meeting/Dividend - Re 0.05 Per Share
2016-09-22	Dividend	Annual General Meeting/Dividend - Re 0.10 Per Share
2015-09-22	Dividend	Annual General Meeting/ Dividend - Re 0.10/- Per Share
2014-08-21	Dividend	Annual General Meeting / Final Dividend - Re 0.10/- Per Share
2013-09-19	Dividend	Annual General Meeting And Dividend Re.0.10 Per Share
2012-09-20	Dividend	Annual General Meeting And Dividend Re.0.10 Per Share
2011-09-21	Dividend	Annual General Meeting And Dividend Re.0.10 Per Share
2010-09-23	Other	Annual General Meeting
2010-01-21	Other	Int Div-Re.0.25 Per Sharepurpose Revised
2009-09-03	Other	Agm/Div-Re.0.10 Per Share
2008-11-12	Split	Fv Split Rs.10/- To Re.1/
2008-09-18	Dividend	Agm/Dividend - 40%

Earnings Transcripts

Nectar Lifesciences Limited has informed the Exchange regarding 'Investor Presentation (Q3 FY25)'.

31 Jan 2025NSE11K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-04-27	12.00	12.69	12.00	12.56	3.29L
2026-04-24	12.20	12.20	11.70	11.79	3.07L
2026-04-23	12.30	12.64	11.80	12.06	5.51L
2026-04-22	12.18	12.35	12.03	12.22	2.12L
2026-04-21	12.35	12.50	12.06	12.17	2.33L
2026-04-20	12.73	12.86	12.15	12.29	3.54L
2026-04-17	12.50	13.03	12.50	12.67	7.26L
2026-04-16	12.45	12.50	12.15	12.41	5.00L
2026-04-15	12.50	12.50	12.07	12.29	5.10L
2026-04-13	11.49	12.60	11.10	11.90	12.34L
2026-04-10	10.85	11.75	10.82	11.75	6.33L
2026-04-09	10.93	11.05	10.58	10.69	4.88L
2026-04-08	10.40	10.97	10.21	10.79	9.37L
2026-04-07	10.06	10.13	9.97	9.98	4.33L
2026-04-02	9.99	10.23	9.71	10.04	5.97L
2026-04-01	9.48	9.76	9.48	9.76	1.26L
2026-03-27	10.38	10.38	9.78	9.78	8.76L
2026-03-25	10.75	10.89	10.12	10.29	6.67L
2026-03-24	10.43	10.85	10.40	10.43	3.15L
2026-03-20	11.09	11.37	10.94	10.96	2.96L
2026-03-19	11.14	11.42	11.01	11.09	4.19L
2026-03-18	10.95	11.32	10.95	11.21	4.82L
2026-03-17	11.09	11.20	10.80	10.95	3.68L
2026-03-16	11.09	11.49	10.94	11.09	4.51L
2026-03-13	11.68	11.84	10.86	11.09	16.79L
2026-03-12	11.74	11.74	11.30	11.33	2.72L
2026-03-11	11.57	11.90	11.30	11.42	3.01L
2026-03-10	11.50	11.53	11.22	11.35	3.30L
2026-03-09	11.31	11.71	11.13	11.29	3.34L
2026-03-06	11.70	11.94	11.68	11.71	1.92L

Frequently Asked Questions

About

Nectar Lifesciences Limited is a global pharmaceutical company specializing in the manufacturing and marketing of cephalosporin antibiotics, oral and sterile formulations, and phytochemicals. With a significant manufacturing facility in India and approvals from regulatory bodies like USFDA and EUGMP, it stands as India's largest stock broker by active users on NSE.